Weight-Loss drug before heart procedure may boost success in AF patients
NCT ID NCT07275697
First seen Jan 04, 2026 · Last updated May 07, 2026 · Updated 22 times
Summary
This study tests whether taking semaglutide (Wegovy) before a standard heart procedure called catheter ablation can help people with atrial fibrillation (an irregular heartbeat) stay free of heart rhythm problems for longer. The trial will enroll 200 adults who are overweight or obese and scheduled for their first ablation. Half will receive semaglutide plus lifestyle advice before the procedure, while the other half gets standard care. All participants will get a small heart monitor implanted to track their rhythm for a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karolinska University Hospital
Stockholm, 141 86, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.